A detailed history of Trust CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Trust CO holds 11,983 shares of BMY stock, worth $637,375. This represents 0.08% of its overall portfolio holdings.

Number of Shares
11,983
Previous 14,331 16.38%
Holding current value
$637,375
Previous $595,000 4.2%
% of portfolio
0.08%
Previous 0.08%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

SELL
$39.66 - $51.75 $93,121 - $121,509
-2,348 Reduced 16.38%
11,983 $620,000
Q2 2024

Jul 15, 2024

SELL
$40.25 - $52.99 $181,809 - $239,355
-4,517 Reduced 23.97%
14,331 $595,000
Q1 2024

Apr 11, 2024

BUY
$47.98 - $54.4 $769,167 - $872,086
16,031 Added 569.08%
18,848 $1.02 Million
Q4 2023

Jan 10, 2024

SELL
$48.48 - $57.85 $42,274 - $50,445
-872 Reduced 23.64%
2,817 $144,000
Q3 2023

Dec 04, 2023

SELL
$57.89 - $64.73 $295,007 - $329,864
-5,096 Reduced 58.01%
3,689 $214,000
Q2 2023

Jul 10, 2023

SELL
$63.71 - $70.74 $16,054 - $17,826
-252 Reduced 2.79%
8,785 $561,000
Q1 2023

Apr 07, 2023

SELL
$65.71 - $74.53 $8,082 - $9,167
-123 Reduced 1.34%
9,037 $626,000
Q4 2022

Jan 09, 2023

SELL
$68.48 - $81.09 $3,150 - $3,730
-46 Reduced 0.5%
9,160 $659,000
Q3 2022

Oct 11, 2022

BUY
$0.13 - $76.84 $10 - $5,993
78 Added 0.85%
9,206 $654,000
Q2 2022

Jul 06, 2022

SELL
$72.62 - $79.98 $904,917 - $996,630
-12,461 Reduced 57.72%
9,128 $703,000
Q1 2022

Apr 08, 2022

SELL
$61.48 - $73.72 $125,234 - $150,167
-2,037 Reduced 8.62%
21,589 $1.58 Million
Q4 2021

Jan 14, 2022

BUY
$53.63 - $62.52 $41,241 - $48,077
769 Added 3.36%
23,626 $1.47 Million
Q3 2021

Oct 20, 2021

BUY
$59.17 - $69.31 $344,428 - $403,453
5,821 Added 34.17%
22,857 $1.35 Million
Q2 2021

Jul 14, 2021

SELL
$61.91 - $67.42 $15,910 - $17,326
-257 Reduced 1.49%
17,036 $1.14 Million
Q1 2021

Apr 08, 2021

BUY
$59.34 - $66.74 $6,942 - $7,808
117 Added 0.68%
17,293 $1.09 Million
Q4 2020

Jan 12, 2021

SELL
$57.74 - $65.43 $192,447 - $218,078
-3,333 Reduced 16.25%
17,176 $1.07 Million
Q3 2020

Oct 06, 2020

SELL
$57.43 - $63.64 $23,661 - $26,219
-412 Reduced 1.97%
20,509 $1.24 Million
Q2 2020

Jul 17, 2020

BUY
$54.82 - $64.09 $158,155 - $184,899
2,885 Added 16.0%
20,921 $1.23 Million
Q1 2020

Apr 07, 2020

SELL
$46.4 - $67.43 $55,030 - $79,971
-1,186 Reduced 6.17%
18,036 $1.01 Million
Q4 2019

Jan 07, 2020

BUY
$49.21 - $64.19 $5,462 - $7,125
111 Added 0.58%
19,222 $1.23 Million
Q3 2019

Oct 09, 2019

SELL
$42.77 - $50.71 $135,409 - $160,547
-3,166 Reduced 14.21%
19,111 $969,000
Q2 2019

Jul 08, 2019

SELL
$44.62 - $49.34 $2.35 Million - $2.6 Million
-52,638 Reduced 70.26%
22,277 $1.01 Million
Q1 2019

Apr 08, 2019

SELL
$45.12 - $53.8 $493,522 - $588,464
-10,938 Reduced 12.74%
74,915 $3.57 Million
Q4 2018

Jan 22, 2019

BUY
$48.76 - $63.23 $4.03 Million - $5.23 Million
82,653 Added 2582.91%
85,853 $4.46 Million
Q1 2018

Apr 09, 2018

SELL
$59.92 - $68.98 $20,013 - $23,039
-334 Reduced 9.45%
3,200 $202,000
Q4 2017

Jan 11, 2018

BUY
$59.94 - $65.35 $59,940 - $65,349
1,000 Added 39.46%
3,534 $217,000
Q3 2017

Oct 12, 2017

BUY
$55.23 - $63.74 $139,952 - $161,517
2,534
2,534 $162,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Trust CO Portfolio

Follow Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Trust CO with notifications on news.